Pelayaran Nasional Ekalya Purnamasari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Pelayaran Nasional Ekalya Purnamasari Tbk. trades at Rp1,015 (market cap 7.59T, 765K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.18M 24h volume). The key difference: Pelayaran Nasional Ekalya Purnamasari Tbk. is far larger — about 13.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 765K). Which is the better fit depends on your goals.
| ELPI | LABS | |
|---|---|---|
Market Cap | 7.59T | 576.7B |
Volume | 765K | 3.18M |
Lot | 7.65K | 31.76K |
Turnover | 779.38M | 477.65M |
Average Price | 1,018.8 | 150.39 |
Value | 779.38M | 477.65M |
Indicative Equilibrium Price | 990 | 147 |
Indicative Equilibrium Volume | 18.1K | 311 |
Trailing returns across standard periods
Latest headlines on both assets
PT Pelayaran Nasional Ekalya Purnamasari Tbk (the Entity) was established based on Notarial Deed No. 11 of Grace Margareth Goenawan, S.H., dated April 20, 1992 in Ambon. PT Pelayaran Nasional Ekalya Purnamasari is the parent Entity, whereas PT Kreasi Cipta Timur is the ultimate parent of the Entity. The Entity’s Ultimate Beneficiary Ownership (UBO) is Eka Taniputra.
Read more on ELPI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →